Results 131 to 140 of about 4,211,254 (290)

Surgical revolution vs surgical evolution [PDF]

Eye, 2007
openaire   +2 more sources

Surgical horizons.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1965
No Abstract.
openaire   +2 more sources

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

Surgical Management of Intracranial Atherosclerotic Disease: Current Evidence and Future Directions in Stroke Prevention

Journal of Vascular Diseases
Background: Intracranial atherosclerotic disease (ICAD) remains a major global cause of ischemic stroke—particularly in Asian, Black, and Hispanic populations—and is characterized by high recurrence rates despite advances in intensive medical management.
Enes Demir, Deondra Montgomery, Henry Freeman, Maryam Zeinali, Denise Baloi, Brandon Lucke-Wold, Michael Karsy   +6 more
doaj   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

An interpretable nomogram with SHAP analysis predicts thrombotic failure of forearm arteriovenous fistulas

Frontiers in Surgery
ObjectiveEnd-stage renal disease is an increasing global health problem. Arteriovenous fistula (AVF) thrombosis is a major cause of access failure in maintenance hemodialysis (MHD) patients.
Yilin Xu, Linsen Jiang, Haixia Zhang, Rong Ni, Peng Qian, Zhi Wang, Weiwei Li   +6 more
doaj   +1 more source

Surgical personalities, surgical burnout, and surgical happiness [PDF]

Journal of Vascular Surgery, 2017
openaire   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Investigate the hemodynamic alterations and anxiety state levels during the surgical disimpaction of mandibular third molar

Journal of Education and Health Promotion
BACKGROUND: This study investigates the haemodynamic responses during the disimpaction process to enhance clinical awareness and perioperative care. MATERIALS AND METHODS: A prospective cohort study was conducted with 140 participants aged 18 years and ...
Addu Aravind Kumar, Siddharth Paladugu, Muthahera Mazhar, Godvine Sarepally, Anusha Borra, Himaja Kasarla, Mohammed Abidullah   +6 more
doaj   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source